WuXi Biologics Executive and Leadership Team

Jimmy Li, the Chief Executive Officer at WuXi Biologics, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the expansion of integrated technology platforms, the Chief Executive Officer ensures the company maintains a competitive edge in the global biologics market. This leadership role involves constant engagement with the Board to align operational goals with international growth targets. Jimmy Li drives the execution of complex drug development initiatives, ensuring that the firm provides efficient, scalable solutions for pharmaceutical partners worldwide. Through rigorous oversight of internal processes, the Chief Executive Officer optimizes resource allocation across all regional divisions. The strategic direction provided by Li fosters innovation in biologics manufacturing, ultimately securing the company's position as a leader in the life sciences sector while maintaining high standards of operational excellence and scientific integrity.

Ming Tu, the Chief Financial Officer at WuXi Biologics, manages the fiscal health and capital allocation strategies for the entire enterprise. Overseeing global financial reporting, the Chief Financial Officer ensures transparency and compliance across all international markets. This role involves coordinating with the executive team to fund large-scale infrastructure projects and research initiatives that support the company's integrated technology platforms. Ming Tu directs the financial planning and analysis functions, providing the necessary data to drive informed decision-making at the highest levels. By monitoring market trends and economic shifts, the Chief Financial Officer mitigates financial risks while maximizing shareholder value. Through disciplined management of assets and liabilities, Tu secures the necessary capital to fuel continuous growth in the biologics industry, ensuring that the firm remains financially robust while delivering high-value services to global pharmaceutical clients.

Jijie Gu, the Chief Scientific Officer, President of Global Biologics Research at WuXi Biologics, directs the scientific vision and research strategy for the entire organization. Overseeing the discovery and development of novel biologics, the Chief Scientific Officer, President of Global Biologics Research ensures that the company remains a pioneer in scientific innovation. This role involves leading large-scale research teams to identify and validate new therapeutic targets for global pharmaceutical clients. Jijie Gu directs the integration of advanced research methodologies into the company's technology platforms, ensuring that all projects meet rigorous scientific standards. By fostering collaboration between internal research units and external partners, the Chief Scientific Officer, President of Global Biologics Research drives the creation of high-impact drug candidates. Through the continuous pursuit of scientific excellence, Gu secures the firm's reputation as a leader in the biologics field, ultimately advancing the development of life-saving treatments.

Xuejun (Sherry) Gu, the Chief Technology Officer at WuXi Biologics, architects the technical infrastructure and digital platforms essential for modern biologics development. Overseeing the integration of advanced manufacturing technologies, the Chief Technology Officer ensures that the company remains at the forefront of scientific innovation. This role involves collaborating with research teams to streamline the transition from drug discovery to commercial production. Xuejun (Sherry) Gu directs the implementation of cutting-edge laboratory systems that enhance efficiency and data accuracy across all global facilities. By focusing on technological scalability, the Chief Technology Officer supports the rapid development of complex biologics for diverse client needs. Through the continuous refinement of proprietary platforms, Gu drives the technical evolution of the firm, ensuring that all operational workflows meet the highest industry standards for quality, speed, and reliability in the competitive global pharmaceutical landscape.

Jessica Liu, the Chief Human Resources Officer & Executive Vice President at WuXi Biologics, manages the global talent strategy and organizational development initiatives. Overseeing the recruitment and retention of top-tier scientific and technical professionals, the Chief Human Resources Officer & Executive Vice President ensures that the company maintains a high-performance culture. This role involves designing comprehensive training programs that align with the firm's mission to advance biologics drug development. Jessica Liu directs the implementation of human capital policies that support growth across diverse international regions. By fostering an environment of continuous learning and professional development, the Chief Human Resources Officer & Executive Vice President strengthens the internal capabilities required to support complex research projects. Through strategic workforce planning, Liu ensures that the organization possesses the necessary expertise to meet the evolving demands of the global pharmaceutical industry while maintaining operational stability.

Sherry Gu, the Executive Vice President & Chief Technology Officer at WuXi Biologics, leads the strategic deployment of advanced manufacturing processes and digital transformation initiatives. Overseeing the technical roadmap, the Executive Vice President & Chief Technology Officer ensures that the company's integrated platforms remain highly efficient and scalable. This role involves working closely with the research and development departments to optimize the lifecycle of biologics products. Sherry Gu directs the adoption of innovative engineering solutions that reduce time-to-market for pharmaceutical partners. By focusing on the intersection of technology and biology, the Executive Vice President & Chief Technology Officer enhances the firm's ability to handle complex drug development challenges on a global scale. Through the rigorous application of technical standards, Gu ensures that all manufacturing operations deliver consistent, high-quality results, thereby supporting the company's overarching goal of providing superior service to the global life sciences market.